http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190053090-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_050fc7b82c5d17d9aeb63a7cdcc546b3 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C391-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4035 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4035 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C391-00 |
| filingDate | 2018-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5681650a38dfd5ada9d935a8a6594793 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf6223ac6f330df7db48d38e85ab1580 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0366ab8e0611f0bf1f36e40d4aab9945 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6732bc4319ef832b78cafa62c5fdd6a6 |
| publicationDate | 2019-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20190053090-A |
| titleOfInvention | Seleno-psammaplin A and its derivatives, preparation method thereof, and pharmaceutical compositions for the prevention and treatment of cancer containing the same as an active ingredient |
| abstract | The present invention relates to novel selenosamphilin A and derivatives thereof having anticancer activity, a process for producing the same, and a pharmaceutical composition containing the same as an active ingredient. More specifically, the present invention relates to tamoxifen A And a novel compound Selenosamphilin A and derivatives thereof which exhibit superior anticancer activity by disulfide substitution with diselenide according to structural activity studies, a process for producing the same, and a composition for preventing or treating cancer comprising the same as an active ingredient . The novel selenosamphilin A and its derivatives according to the present invention show excellent anticancer activity against various human cancer cell lines and are expected to be useful as a pharmaceutical composition for cancer prevention and treatment. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102076263-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021054510-A1 |
| priorityDate | 2017-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 136.